Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Meredith Perpetua"'
Autor:
Heeringa Katharine, Allison R. Greenplate, Meredith Perpetua, Randall J. Brezski, Gregory Bannish, Robert Jordan, Frank Lynch, Stephen G. McCarthy, Katharine D. Grugan, Michelle Kinder, William R. Strohl, Keri L. Soring
Publikováno v:
Journal of Biological Chemistry. 288:30843-30854
Molecularly engineered antibodies with fit-for-purpose properties will differentiate next generation antibody therapeutics from traditional IgG1 scaffolds. One requirement for engineering the most appropriate properties for a particular therapeutic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15ac0b3bd9a3b0710d27bc695d73ab29
https://doi.org/10.1074/jbc.m113.486142
https://doi.org/10.1074/jbc.m113.486142
Publikováno v:
Toxicology Letters. 229:S206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b9012c776417f5c968a0450054f64d8
https://doi.org/10.1016/j.toxlet.2014.06.693
https://doi.org/10.1016/j.toxlet.2014.06.693
Autor:
Simon T. Bate, Gareth Thomas, Dorie Makropoulos, Mindi Walker, Peter J. Bugelski, Meredith Perpetua, Gregory Bannish
Publikováno v:
Blood. 116:2778-2778
Abstract 2778 Monoclonal antibodies (mAb) are widely used in anti-inflammatory and tumor therapy. They are highly effective in certain diseases, but can cause a range of adverse effects. Toxicity may result from the expected pharmacological effects o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6308fe2e91992ddce7d6d87d72f725e
https://doi.org/10.1182/blood.v116.21.2778.2778
https://doi.org/10.1182/blood.v116.21.2778.2778